Jump Financial, LLC Prometheus Biosciences, Inc. Transaction History

Jump Financial, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$36.06 - $117.21 $1.3 Million - $4.23 Million	36,120 New	36,120 $3.97 Million
Q2 2022 Aug 09, 2022	BUY	$22.39 - $38.94 $429,888 - $747,648	19,200 New	19,200 $542,000
Q1 2022 May 12, 2022	SELL	$30.13 - $50.0 $174,814 - $290,100	-5,802 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$22.28 - $39.54 $129,268 - $229,411	5,802 New	5,802 $229,000
Q3 2021 Nov 12, 2021	SELL	$20.89 - $26.96 $215,396 - $277,984	-10,311 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$16.8 - $29.65 $173,224 - $305,721	10,311 New	10,311 $253,000

29.6K

Ticker RXDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,904,100
Description
Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.